Evidence map›Paper›PMID 33567639›Full record

ArticleMolecules (Basel, Switzerland)2021

Chemical Composition, Apoptotic Activity, and Antiparasitic Effects of

Mohamed S Alyousif, Hiba Riyadh Al-Abodi, Hamdan Almohammed, Abdullah D Alanazi, Hossein Mahmoudvand, Marzieh Hakami Shalamzari, Iraj Salimikia

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Frontiers in pharmacology · 2025
    Article
  6. Potential activity ofFrontiers in pharmacology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Chemical composition, antileishmanial, and cytotoxic effectsParasite epidemiology and control · 2022
    Article
  14. Article
  15. Review
  16. Acaricidal, Larvacidal, and Repellent Activity ofPlants (Basel, Switzerland) · 2022
    Article
  17. Antiparasitic effects ofSaudi journal of biological sciences · 2022
    Article
  18. Therapeutic Potential and Safety of theFrontiers in cellular and infection microbiology · 2022
    Article
  19. Article
  20. In vitro and in vivo Anti-Infection and drug resistance · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Mohamed S AlyousifDepartment of Zoology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
Hiba Riyadh Al-AbodiDepartment of Environment, College of Science, University of Al-Qadisiyah, Al-Diwaniyah 58001, Iraq.
Hamdan AlmohammedDepartment of Microbiology and Parasitology, Almaarefa University, Riyadh 11597, Saudi Arabia.
Abdullah D AlanaziDepartment of Biological Science, Faculty of Science and Humanities, Shaqra University, Ad-Dawadimi 11911, Saudi Arabia.ORCID 0000-0002-4862-7668
Hossein MahmoudvandHepatitis Research Center, Lorestan University of Medical Sciences, Khorramabad 6813833946, Iran.
Marzieh Hakami ShalamzariStudent Research Committee, Lorestan University of Medical Sciences, Khorramabad 6813833946, Iran.
Iraj SalimikiaRazi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad 6813833946, Iran.
Lorestan University of Medical Sciences · IRAlfaisal University · SAKing Saud University · SAShaqra University · SAUniversity of Al-Qadisiyah · IQ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundToday, the present protoscolicidals used to minimize the serious risks during hydatid cyst surgery are not completely safe and have various adverse side effects. The present study aimed to evaluate the chemical composition and apoptotic activity of

methodsGas chromatography/mass spectrometry (GC/MS) analysis was performed to determine the chemical composition of FMEO. Protoscoleces of hydatid cysts were collected from liver fertile hydatid cysts of infected sheep and were then treated with various concentrations of the essential oil (75, 150, and 300 µL/mL) for 5-60 min in vitro and ex vivo. Then, by using the eosin exclusion test, the viability of the protoscoleces was studied. The caspase-3-like activity of the FMEO-treated protoscoleces was also evaluated through the colorimetric protease assay Sigma Kit based on the manufacturer's instructions.

resultsAccording to GC/MS, the main constituents of the essential oil were terpinolene (77.72%), n-nonanal (4.47%), and linalool (4.35%), respectively. In vitro, the maximum protoscolicidal activity of FMEO was observed at the concentrations of 150 and 300 µL/mL, such that 100% of the protoscoleces were killed after 30 and 20 min of exposure, respectively. Based on the obtained findings, the results demonstrate that FMEO required a longer time to kill protoscoleces ex vivo; after 12 min of exposure to FMEO, only 13.4% of the protoscoleces remained alive. After 48 h of the treatment of protoscoleces, FMEO, in a dose-dependent manner and at doses of 75, 150, and 300 µL/mL, induced the activation of the caspase enzyme by 24.3, 35.3, and 48.3%, respectively.

conclusionsOur findings demonstrate the potent protoscolicidal effects of FMEO in vitro and ex vivo; however, further studies are required to assess the safety and the efficiency of FMEO as a promising scolicidal agent in a preclinical model and clinical setting.

Indexed as

AnimalsAntiparasitic AgentsApoptosisEchinococcus granulosusFerulaOils, VolatileAntiparasitic AgentsOils, Volatileapoptosiscaspase activitycystic echinococcosisherbal medicinescolicidal

Identifiers

PMID33567639
PMCPMC7914769
OpenAlexW3127516747

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.